Ortodontijos laboratorija - Company finances
|
EUR
|
2023
From: 2023-02-24
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | - | 30,509 | 40,761 |
| Profit before tax | -325 | 17,230 | 15,135 |
| Net profit | -325 | 16,384 | 14,188 |
| Equity | -324 | 16,060 | 13,888 |
| Liabilities | 500 | 3,226 | 1,432 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 176 | 19,286 | 15,320 |
| Total assets | 176 | 19,286 | 15,320 |
|
Taxes paid
|
|||
| STI taxes | 325 | - | 2,297 |
|
Financial indicators
|
|||
| Revenue change y/y | - | - | +33.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -184.7% | 85.0% | 92.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 102.0% | 102.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 53.7% | 34.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 56.5% | 37.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ortodontijos laboratorija - Social security debts
The company had no debts to Sodra
Ortodontijos laboratorija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-05 | 2025-03-31 | 0.55 |
| 2025-03-02 | 2025-03-04 | 612.23 |
| 2025-02-28 | 2025-03-01 | 608.6 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ortodontijos laboratorija, MB (code 306256034) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In the latest financial year, 2025, revenue reached €40.8K, increasing by 33.6% year on year from €30.5K in 2024. Net profit amounted to €14.2K in 2025, compared with €16.4K in 2024, while the profit margin decreased to 34.8% from 53.7%. The company’s trajectory improved materially from 2023, when it reported a net loss of €325 and negative equity of €324, to positive profitability in both 2024 and 2025. At the end of 2025, total assets were €15.3K, equity €13.9K and liabilities €1.4K, showing a balance sheet financed mainly by equity. Key ratios for 2025 point to efficient use of assets, with asset turnover of 2.66x, ROE of 102.2% and ROA of 92.6%, alongside a debt-to-equity ratio of 0.10 and an equity ratio of 90.7%.